Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes

Journal of Clinical Investigation(2025)10.1172/jci176403Source: DataRank Database

Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

geo nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.82)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Pierre Lemaître ORCID,Laura Martínez-Calvo ORCID,Francesca Lodi ORCID,Álvaro Cortés Calabuig ORCID,Samal Bissenova ORCID

Live enrichment

PubMed:41026533 PMC:PMC12646666 OpenAlex:https://openalex.org/W4414653110

Flemish Research Foundation

Grant: 11A0220N

NIAID NIH HHS

Grant: UM1 AI109565

KU Leuven

Grant: small research infrastructure grant (KA/20/077)

KU Leuven

Grant: C1/18/006,C16/18/006

Flemish Research Foundation

Grant: G.0C63.19N,G.0667.21N,G.0316.25N

FWCI

3.82

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttp://www.jci.org/articles/view/176403/files/pdf

publisherhttp://www.jci.org/articles/view/176403/files/pdf

journalhttps://doi.org/10.1172/jci176403

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41026533

repositoryhttps://lirias.kuleuven.be/handle/20.500.12942/774803

Fields of Study

Diabetes and associated disordersImmune Cell Function and InteractionAdrenal Hormones and DisordersDiabetes Mellitus, Type 1Antibodies, Monoclonal, HumanizedHumansNeutrophilsAnimalsMiceMice, Inbred NODTranscriptomeFemaleMaleDrug ResistanceCD8-Positive T-Lymphocytes

MeSH Terms

AnimalsDiabetes Mellitus, Type 1Drug ResistanceFemaleHumansMaleNeutrophilsMice, Inbred NODCD8-Positive T-LymphocytesMiceTranscriptomeAntibodies, Monoclonal, Humanized

Keywords

Gene signatureImmune systemGene expression profilingTranscriptomeAntibodyType 1 diabetesAcquired immune systemInnate immune systemHuman leukocyte antigenNeutrophilsImmunotherapyDiabetesAutoimmunityendocrinology

Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes

FAIR Checklist

Authors (15)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)